Aptus Capital Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34.6M	Buy	270,719 +268,234	+10,794%	+$33.5M	0.29%	74
2025 Q4	$303K	Buy	2,485 +446	+22%	+$51.1K	﹤0.01%	882
2025 Q3	$204K	Buy	2,039 +1	+0%	+$90	﹤0.01%	976
2025 Q2	$169K	Hold	2,038	–	–	﹤0.01%	980
2025 Q1	$165K	Buy	2,038 +1,572	+337%	+$141K	﹤0.01%	928
2024 Q4	$41.9K	Sell	466 -235	-34%	-$22.8K	﹤0.01%	1131
2024 Q3	$69.3K	Hold	701	–	–	﹤0.01%	892
2024 Q2	$65K	Sell	701 -64	-8%	-$5.74K	﹤0.01%	868
2024 Q1	$72.6K	Buy	765 +2	+0.3%	+$186	﹤0.01%	858
2023 Q4	$68.1K	Sell	763 -1,015	-57%	-$75.4K	﹤0.01%	649
2023 Q3	$130K	Buy	1,778 +313	+21%	+$25K	﹤0.01%	600
2023 Q2	$122K	Sell	1,465 -25	-2%	-$2.09K	﹤0.01%	518
2023 Q1	$114K	Buy	1,490 +794	+114%	+$65.9K	﹤0.01%	510
2022 Q4	$57.8K	Hold	696	–	–	﹤0.01%	583
2022 Q3	$55K	Buy	696 +251	+56%	+$21.2K	﹤0.01%	548
2022 Q2	$33K	Hold	445	–	–	﹤0.01%	503
2022 Q1	$40K	Buy	445 +82	+23%	+$7.57K	﹤0.01%	525
2021 Q4	$41K	Buy	+363	New	+$43.8K	﹤0.01%	437